Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance

Aim: Resistance to chemotherapy is a major limiting factor that hamper the effectiveness of anticancer therapies. Doxorubicin is an antineoplastic agent used in the treatment of a wide range of cancers. However, it presents several limitations such as dose-dependent cardiotoxicity, lack of selectivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessone, Federica, Dianzani, Chiara, Argenziano, Monica, Cangemi, Luigi, Spagnolo, Rita, Maione, Federica, Giraudo, Enrico, Cavalli, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019188/
https://www.ncbi.nlm.nih.gov/pubmed/35582009
http://dx.doi.org/10.20517/cdr.2020.65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019188/
https://www.ncbi.nlm.nih.gov/pubmed/35582009
http://dx.doi.org/10.20517/cdr.2020.65

Ejemplares similares